Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Windtree Therapeutics Inc
(NQ:
WINT
)
3.290
UNCHANGED
Streaming Delayed Price
Updated: 3:57 PM EDT, Jul 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,784,275
Open
3.290
Bid (Size)
7.430 (10)
Ask (Size)
7.490 (1)
Prev. Close
3.290
Today's Range
3.290 - 3.290
52wk Range
2.810 - 30.06
Shares Outstanding
5,148,219
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Is BurgerFi International (BFI) Stock Up 71% Today?
Today 8:14 EDT
BurgerFi International stock is up on Friday as investors in BFI react to it reaching a settlement agreement with Lion Point Capital, LP.
Via
InvestorPlace
Why Is Windtree Therapeutics (WINT) Stock Up 116% Today?
Today 8:01 EDT
Windtree Therapeutics stock is up on Friday with heavy trading of WINT shares following an update on its clinical trials.
Via
InvestorPlace
Performance
YTD
-73.82%
-73.82%
1 Month
+0.30%
+0.30%
3 Month
-35.11%
-35.11%
6 Month
-59.15%
-59.15%
1 Year
-87.04%
-87.04%
More News
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Today 7:36 EDT
Via
InvestorPlace
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Today 5:57 EDT
Via
Benzinga
(WINT) - Analyzing Windtree Therapeutics's Short Interest
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 24, 2024
Via
InvestorPlace
Why Windtree Therapeutics (WINT) Stock Is Getting Hammered
April 18, 2024
Via
Benzinga
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 18, 2024
Via
Benzinga
WINT Stock Earnings: Windtree Therapeutics Beats EPS for Q4 2023
April 17, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 02, 2024
Via
Benzinga
Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
January 29, 2024
Via
Benzinga
Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
January 26, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
January 25, 2024
Via
Benzinga
Week in Review: Lee’s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy
January 20, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
January 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 18, 2024
Via
Benzinga
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
January 18, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 17, 2024
Via
Benzinga
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
January 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
January 03, 2024
Via
Benzinga
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024
December 19, 2023
Via
ACCESSWIRE
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
December 18, 2023
Via
Benzinga
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
October 10, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.